MMP7 and diabetic kidney disease: In addition, a decrease in serum MMP7 levels has also been shown following treatment of diabetic kidney disease with a sodium–glucose cotransporter 2 inhibitor, likely reflecting an improvement in extracellular matrix turnover and fibrosis31.